Q3 2017 EPS Estimates for Array BioPharma Inc. Cut by SunTrust Banks

Q3 2017 EPS Estimates for Array BioPharma Inc. Cut by SunTrust Banks


Array BioPharma Inc. - Equities research analysts at SunTrust Banks decreased their Q3 2017 earnings estimates for shares of Array BioPharma in a research note issued on Tuesday. SunTrust Banks analyst P. Lawson now forecasts that the brokerage will post earnings per share of for the quarter, down from their prior forecast of .



from Biotech News